Results 171 to 180 of about 5,662,994 (304)

Paracetamol prescriptions in older people hospitalized in a French geriatric hospital

Health Science Reports, 2023
Frederic Baud, Nadia Ladjouzi, Jihène Ben Hassen, Nesrine El Omeiri, Hendriniainia Raveloson, Lucile Brondin, Camille Ben Rahal, Cid Ould Ouali, Georges Zouloumis, Joël Schlatter   +9 more
doaj   +1 more source

Safety and efficacy of intravenous onasemnogene abeparvovec gene therapy in patients with spinal muscular atrophy type 1: interim analysis from LT-001, a long-term follow-up study of patients from the START study. [PDF]

EClinicalMedicine
Waldrop MA, Escudero RB, Yang L, Camarata RA, Branic EC, Mehl L, Ilić A, Connolly AM.   +7 more
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

Molecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner, Pierre Tennstedt, Randi C. Pose, Christian Müller, Katharina Besler, Svenja Schneegans, Malik Alawi, Marie C. Roesch, Sven Peine, Desiree Bonci, Joanna Budna‐Tukan, Evi Lianidou, Catherine Alix‐Panabières, Derya Tilki, Klaus Pantel   +14 more
wiley   +1 more source

Ultra-high dose rate electron FLASH beam irradiation using a modified clinical linear accelerator. [PDF]

PLoS One
Cho GS, Kim KT, Lee SS, Kim JH, Lee DH, Chang HS, Choi SH, Kim KB, Yang TK, An DH, Kim GB, Kang KU, Kang JK, Kim EJ, Paik EK, Kim MS, Jang WI, Yang KM.   +17 more
europepmc   +1 more source

Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/mTOR and MMP2‐COL3A1 axis

Molecular Oncology, EarlyView.
CIN85 is highly expressed in osteosarcoma, particularly in metastatic lesions. Its overexpression increases cell migration and Matrigel invasion, while silencing CIN85 suppresses these behaviors. Transcriptome analysis shows that CIN85 regulates MMP2, COL3A1, and Akt/mTOR signaling. Targeting these pathways reverses CIN85‐induced motility, highlighting
Iryna Horak, Iva Staniczková Zambo, Matěj Přikryl, Peter Múdry, Danica Zapletalová, Jarmila Navrátilová, Jiří Navrátil, Jan Šmarda, Liudmyla Drobot, Petr Beneš, Lucia Knopfová   +10 more
wiley   +1 more source

Japan’s emerging role in bridging immunisation gap and supporting global health

BMJ Global Health
Yoshiki Tanaka, Hayase Hakariya, Aomi Katagiri, Yuka Iijima, Hikari Ohyama, Takuya Nakazawa   +5 more
doaj   +1 more source

Mapeando o mundo dos Institutos de Estudos Avançados sediados em Universidades

Estudos Avançados, 2011
Werner Frick, Carsten Dose, Anna Ertel
doaj   +1 more source

MIRD Pamphlet No. 34, Part 1: MIRDct-A Customizable Software Tool for CT Dosimetry. [PDF]

J Nucl Med
Ocampo Ramos JC, Kofler C, Dawson R, Baggett J, Dinwiddie LE, Domal SJ, Carter LM, Marquis H, Kayal G, Zanzonico PB, Bolch WE, Kesner AL.   +11 more
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Characterization of the Intestinal Metabolic Profiles Following Photon FLASH Irradiation. [PDF]

Dose Response
Zhang S, Peng Q, Zhang J, Wang Z, Cheng X, Zhang Y, Cao Z.   +6 more
europepmc   +1 more source